UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
‘China’s healthcare market continues to grow rapidly’
by Nam Doo-hyun
2018-12-28 14:45
‘Demand for point-of-care devices to rise because of population aging’
by Nam Doo-hyun
2018-12-27 14:45
‘Ministries should collaborate to enlarge surgical robotics market’
by Nam Doo-hyun
2018-12-27 14:44
Newly listed pharmaceuticals suffer market cap declines
by Nam Doo-hyun
2018-12-21 15:13
Consumer healthcare giant born out of GSK-Pfizer tie-up
by Nam Doo-hyun
2018-12-20 14:40
라인
Local firms rush to develop blinding disease treatments
by Nam Doo-hyun
2018-12-20 14:37
‘ASEAN provides growth opportunities for Korean healthcare firms’
by Nam Doo-hyun
2018-12-19 15:56
Korea’s botulinum toxin exports rebound in November
by Nam Doo-hyun
2018-12-18 15:51
Will healthcare meetings restore investor confidence in pharmaceuticals?
by Nam Doo-hyun
2018-12-17 15:44
Celltrion Healthcare’s sell-off of domestic sales right raises window-dressing controversy
by Nam Doo-hyun
2018-12-17 12:48
라인
New hepatitis C drugs compete in shrinking market
by Nam Doo-hyun
2018-12-14 15:14
Samsung BioLogics’ market cap rises after accounting issue
by Nam Doo-hyun
2018-12-13 15:33
‘Bispecific antibody market offers promising outlook’
by Nam Doo-hyun
2018-12-12 16:27
‘Korea should protect pathogen resources under Nagoya Protocol’
by Nam Doo-hyun
2018-12-10 15:15
Trade ministry to support research of new biopharmaceutical drugs
by Nam Doo-hyun
2018-12-07 14:54
라인
Local drugmakers rank high in clinical trial approval
by Nam Doo-hyun
2018-12-06 11:15
‘New combo drug could lower blood pressure early’
by Nam Doo-hyun
2018-12-05 14:01
Doctors have fun on concert stage offered by drugmaker
by Nam Doo-hyun
2018-12-04 14:31
Prescriptions of anticancer drugs spiked this year
by Nam Doo-hyun
2018-11-30 13:01
‘Rules to be tougher on patent transfer due to ToolGen case’
by Nam Doo-hyun
2018-11-29 11:48
-
1
2
3
4
5
6
7
8
9
10
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top